- Home
- ONMD vs ALGS Comparison
ONMD vs ALGS Comparison
Compare ONMD & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- ALGS
- Stock Information
- Founded
- ONMD 2006
- ALGS 2018
- Country
- ONMD United States
- ALGS United States
- Employees
- ONMD N/A
- ALGS 68
- Industry
- ONMD
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- ONMD
- ALGS Health Care
- Exchange
- ONMD Nasdaq
- ALGS Nasdaq
- Market Cap
- ONMD 23.9M
- ALGS 71.0M
- IPO Year
- ONMD N/A
- ALGS 2020
- Fundamental
- Price
- ONMD $0.84
- ALGS $19.03
- Analyst Decision
- ONMD
- ALGS Strong Buy
- Analyst Count
- ONMD 0
- ALGS 1
- Target Price
- ONMD N/A
- ALGS $75.00
- AVG Volume (30 Days)
- ONMD 498.5K
- ALGS 562.3K
- Earning Date
- ONMD 12-03-2024
- ALGS 11-06-2024
- Dividend Yield
- ONMD N/A
- ALGS N/A
- EPS Growth
- ONMD N/A
- ALGS N/A
- EPS
- ONMD N/A
- ALGS N/A
- Revenue
- ONMD $1,021,651.00
- ALGS $5,997,000.00
- Revenue This Year
- ONMD N/A
- ALGS N/A
- Revenue Next Year
- ONMD N/A
- ALGS N/A
- P/E Ratio
- ONMD N/A
- ALGS N/A
- Revenue Growth
- ONMD N/A
- ALGS N/A
- 52 Week Low
- ONMD $0.42
- ALGS $6.76
- 52 Week High
- ONMD $4.43
- ALGS $30.00
- Technical
- Relative Strength Index (RSI)
- ONMD 52.31
- ALGS 70.57
- Support Level
- ONMD $0.81
- ALGS $14.65
- Resistance Level
- ONMD $0.87
- ALGS $24.84
- Average True Range (ATR)
- ONMD 0.13
- ALGS 3.00
- MACD
- ONMD -0.00
- ALGS 0.59
- Stochastic Oscillator
- ONMD 53.27
- ALGS 56.96
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.